tradingkey.logo
tradingkey.logo
Buscar

Co-Diagnostics Inc

CODX
Añadir a la lista de seguimiento
2.990USD
-0.090-2.92%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
10.77MCap. mercado
PérdidaP/E TTM

Más Datos de Co-Diagnostics Inc Compañía

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

Información de Co-Diagnostics Inc

Símbolo de cotizaciónCODX
Nombre de la empresaCo-Diagnostics Inc
Fecha de salida a bolsaJul 12, 2017
Director ejecutivoEgan (Dwight H)
Número de empleados132
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 12
Dirección2401 S. Foothill Dr. Suite D
CiudadSALT LAKE CITY
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal84109
Teléfono18014381036
Sitio Webhttps://codiagnostics.com/
Símbolo de cotizaciónCODX
Fecha de salida a bolsaJul 12, 2017
Director ejecutivoEgan (Dwight H)

Ejecutivos de Co-Diagnostics Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--
Mr. Richard Abbott
Mr. Richard Abbott
President
President
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard S. Serbin
Mr. Richard S. Serbin
Independent Director
Independent Director
12.45K
+13.62%
Mr. James B. Nelson
Mr. James B. Nelson
Independent Director
Independent Director
12.36K
+13.71%
Mr. Dwight H. Egan
Mr. Dwight H. Egan
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Dr. Eugene Durenard, Ph.D.
Dr. Eugene Durenard, Ph.D.
Independent Director
Independent Director
--
--
Mr. Edward L. (Ted) Murphy
Mr. Edward L. (Ted) Murphy
Independent Director
Independent Director
--
--
Mr. Brian L. Brown, CPA
Mr. Brian L. Brown, CPA
Chief Financial Officer, Company Secretary
Chief Financial Officer, Company Secretary
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Co-Diagnostics Inc?

Los cinco principales accionistas de Co-Diagnostics Inc son: Mr. Richard S. Serbin

¿Cuántas instituciones poseen acciones de Co-Diagnostics Inc (CODX)?

A fecha de 2026Q1, 75 instituciones poseen acciones de Co-Diagnostics Inc, con un valor de mercado combinado de aproximadamente 248.15K, lo que representa el 6.89% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -158736.00.